Pricing Log in Create free account

Lexaria Bioscience Corp. (LEXX) vs Traws Pharma, Inc. (TRAW)

Lexaria Bioscience Corp. and Traws Pharma, Inc. are both Biotechnology companies. Lexaria Bioscience Corp. and Traws Pharma, Inc. are of similar size ($6.3M and $6.2M). Traws Pharma, Inc. grew revenue faster over the last twelve months: 1,159.3% against 9.08%. Across the 13 metrics below, Traws Pharma, Inc. leads on 7 and Lexaria Bioscience Corp. on 6.

Valuation

Metric LEXX TRAW Biotechnology median
P/E n/m n/m 8.50
P/S 8.91 2.06 9.71
P/B 1.11 3.47 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales 2.36 0.30 9.21
Earnings yield (174.57%) (475.68%) (33.15%)
Free cash flow yield (155.80%) (287.29%) (25.50%)

Profitability

Metric LEXX TRAW Biotechnology median
Gross margin 100.00% 100.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (162.60%) (319.42%) (56.36%)
Return on assets (134.20%) (117.35%) (48.04%)
Return on invested capital (662.56%) 0.00% 0.00%

Growth

Metric LEXX TRAW Biotechnology median
Revenue growth (TTM) 9.08% 1,159.29% 6.02%
EPS growth (last fiscal year) (40.43%) 100.76% 30.26%
Revenue growth, 5-year CAGR 17.53% 64.59% 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric LEXX TRAW Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 10.60 0.93 4.72
Net debt to EBITDA 0.17 0.21 0.96

Dividend

Metric LEXX TRAW Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric LEXX TRAW Biotechnology median
Market cap 6.30m 6.20m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack